BYBEE CLINTON
SEC CIK 1219043 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VIR | Vir Biotechnology, Inc. | 10% | 21.7K | — | — | 4 | 2021-11-29 | 2022-08-18 |
Most active insiders at VIR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SVF Endurance (Cayman) Ltd | 10% | — | $9.38M |
| 2 | SB INVESTMENT ADVISERS (UK) LTD | 10% | — | $5.72M |
| 3 | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | — | $2.76M |
| 4 | SATO VICKI L | Dir | — | $1.73M |
| 5 | De Backer Marianne | Pres, CEO, Dir | — | $946.9K |
| 6 | de Verneuil Vanina | EVP, GC, Corp Sec | — | $217.7K |
| 7 | Sabatini Brent | SVP, CAO | — | $113.1K |
| 8 | O'Byrne Jason | EVP, CFO | — | $68.9K |
| 9 | Eisner Mark | EVP, Chief Medical Off | — | $49.5K |
| 10 | Napolitano Janet | Dir | — | $30.2K |
BYBEE CLINTON made no open-market trades at VIR in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-08-22 | 2022-08-18 | VIR | Vir Biotechnology, Inc. | BYBEE CLINTON | 10% | J - Other | $0.00 | +14.6K | 21.7K | +203% | $0 |
| MI | 2022-08-22 | 2022-08-18 | VIR | Vir Biotechnology, Inc. | BYBEE CLINTON | 10% | J - Other | $0.00 | -497.0K | 6.93M | -7% | $0 |
| MI | 2021-12-01 | 2021-11-29 | VIR | Vir Biotechnology, Inc. | BYBEE CLINTON | 10% | J - Other | $0.00 | -500.0K | 11.67M | -4% | $0 |
| M | 2021-12-01 | 2021-11-29 | VIR | Vir Biotechnology, Inc. | BYBEE CLINTON | 10% | J - Other | $0.00 | +17.5K | 70.4K | +33% | $0 |
Purchase Sale Sale after option exercise All abbreviations